These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24345402)

  • 1. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.
    Mora S; Buring JE; Ridker PM
    Circulation; 2014 Feb; 129(5):553-61. PubMed ID: 24345402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice.
    Varvel SA; Dayspring TD; Edmonds Y; Thiselton DL; Ghaedi L; Voros S; McConnell JP; Sasinowski M; Dall T; Warnick GR
    J Clin Lipidol; 2015; 9(2):247-55. PubMed ID: 25911082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease.
    Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ
    J Diabetes Complications; 2016; 30(1):115-20. PubMed ID: 26481154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein cholesterol versus particle number in middle school children.
    Mietus-Snyder M; Drews KL; Otvos JD; Willi SM; Foster GD; Jago R; Buse JB;
    J Pediatr; 2013 Aug; 163(2):355-62. PubMed ID: 23415622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical association of lipoprotein measures with incident atrial fibrillation.
    Mora S; Akinkuolie AO; Sandhu RK; Conen D; Albert CM
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):612-9. PubMed ID: 24860180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    El Harchaoui K; van der Steeg WA; Stroes ES; Kuivenhoven JA; Otvos JD; Wareham NJ; Hutten BA; Kastelein JJ; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2007 Feb; 49(5):547-53. PubMed ID: 17276177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remnant Cholesterol and the Risk of Coronary Artery Calcium Progression: Insights From the CARDIA and MESA Study.
    Hao QY; Gao JW; Yuan ZM; Gao M; Wang JF; Schiele F; Zhang SL; Liu PM
    Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014116. PubMed ID: 35861979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.
    Akinkuolie AO; Paynter NP; Padmanabhan L; Mora S
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):55-63. PubMed ID: 24248942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.